摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,5-diethyl-piperidine | 116836-21-6

中文名称
——
中文别名
——
英文名称
2,5-diethyl-piperidine
英文别名
2,5-Diaethyl-piperidin;2,5-Diethylpiperidine
2,5-diethyl-piperidine化学式
CAS
116836-21-6
化学式
C9H19N
mdl
MFCD19218949
分子量
141.257
InChiKey
IZLHISLQJGXQCV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 乙醇sodium 作用下, 生成 2,5-diethyl-piperidine
    参考文献:
    名称:
    Prausnitz, Chemische Berichte, 1892, vol. 25, p. 2394
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
    申请人:——
    公开号:US20040010011A1
    公开(公告)日:2004-01-15
    The invention relates to benzofuran or benzothiophene derivatives of general formula: 1 These compounds are of use as medicinal products, in particular in the treatment of pathological syndromes of the cardiovascular system.
    这项发明涉及一般式为苯并呋喃或苯并噻吩衍生物的化合物:1。这些化合物可用作药物产品,特别是用于治疗心血管系统病理综合征。
  • Process for producing catalyst for alpha -olefin polymerization and process for producing alpha -olefin polymer
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:US20030134992A1
    公开(公告)日:2003-07-17
    There are provided a process for producing a catalyst for &agr;-olefin polymerization, which comprises the step of contacting (1) a solid catalyst component having Ti, Mg and a halogen as essential components, (2) an organoaluminum compound and (3) a compound having a —C—O—C—O—C— bond group in a closed ring structure with one another; and a process for producing an &agr;-olefin polymer, which comprises the step of homopolymerizing or copolymerizing an &agr;-olefin in the presence of a catalyst for &agr;-olefin polymerization produced by the above process.
    提供了一种生产烯烃聚合催化剂的工艺,该工艺包括以下步骤:(1)以 Ti、Mg 和卤素为主要成分的固体催化剂组分,(2)有机铝化合物和(3)在闭环结构中具有-C-O-C-O-C-键基的化合物相互接触;以及一种生产&agr;-烯烃聚合物的工艺,该工艺包括在上述工艺生产的&agr;-烯烃聚合催化剂存在下均聚或共聚&agr;-烯烃的步骤。
  • Process for producing catalyst for alpha-olefin polymerization and process for producing alpha-olefin polymer
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:US20040092679A1
    公开(公告)日:2004-05-13
    There are provided a process for producing a catalyst for &agr;-olefin polymerization, which comprises the step of contacting (1) a solid catalyst component having Ti, Mg and a halogen as essential components, (2) an organoaluminum compound and (3) a compound having a —C—O—C—O—C— bond group in a closed ring structure with one another; and a process for producing an &agr;-olefin polymer, which comprises the step of homopolymerizing or copolymerizing an &agr;-olefin in the presence of a catalyst for &agr;-olefin polymerization produced by the above process.
    提供了一种生产烯烃聚合催化剂的工艺,该工艺包括以下步骤:(1)以 Ti、Mg 和卤素为主要成分的固体催化剂组分,(2)有机铝化合物和(3)在闭环结构中具有-C-O-C-O-C-键基的化合物相互接触;以及一种生产&agr;-烯烃聚合物的工艺,该工艺包括在上述工艺生产的&agr;-烯烃聚合催化剂存在下均聚或共聚&agr;-烯烃的步骤。
  • AMINOALKOXYBENZOYL-BENZOFURANES OU BENZOTHIOPHENES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS LES CONTENANT
    申请人:SANOFI-SYNTHELABO
    公开号:EP1315710A1
    公开(公告)日:2003-06-04
  • UREA DERIVATIVES AND USES THEREOF
    申请人:Kala Pharmaceuticals, Inc.
    公开号:US20150072986A1
    公开(公告)日:2015-03-12
    The present invention provides novel compounds of any one of Formulae (I)-(III), and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I)-(III) and pharmaceutical compositions thereof that are mucus penetrating. The invention also provides methods and kits for using the inventive compounds, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration, glaucoma, diabetic retinopathy, retinoblastoma, edema, uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof.
查看更多